PaulHWakefieldMD

Family Medicine • Knoxville, TN

Physician

Join to view full profile

Dr. Wakefield is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Wakefield's full profile

Already have an account?

Office
1208 Merchant Dr
Knoxville, TN 37912
Phone+1 865-688-2522
Is this information wrong?

Education & Training

University of Tennessee Medical Center at KnoxvilleResidency, Family Medicine, 1987 - 1990
University of Tennessee Health Science Center College of MedicineClass of 1987

Certifications & Licensure

TN State Medical License 1988 - 2025

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Diabetes Recognition Program National Committee for Quality Assurance, 2012-2015
Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2011-2013
Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2011-2013
Heart/Stroke Recognition Program National Committee for Quality Assurance, 2011-2014
Diabetes, Cardiac Care Recognition Health Care Incentives Improvement Institute
Join now to see all

Clinical Trials

Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis Start of enrollment: 2013 Dec 01
Completed
Phase 3
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus Start of enrollment: 2010 Jun 18
Completed
Phase 3
The Plecanatide Chronic Idiopathic Constipation (CIC) Study Start of enrollment: 2011 Oct 01
Completed
Phase 2, Phase 3
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC) Start of enrollment: 2013 Aug 01
Completed
Phase 3
A Study of Dulaglutide (LY2189265) in Participants With Type II Diabetes Start of enrollment: 2014 May 01
Completed
Phase 3
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM Start of enrollment: 2015 Sep 01
Completed
Phase 2
Anthrax AV7909 Boost Evaluation Study Start of enrollment: 2023 Dec 05
Recruiting
Phase 2
Roles: Contact
Join now to see all